NIH-funded research R21 grant

Investigating how medications can cause delirium in older adults

Official title: Comprehensive Assessment of Delirium Risk due to Medications

Funded at University of Alabama at Birmingham · NIH-10989899 · Data updated 2026-11-12

This study is looking at how certain medications might lead to delirium in older adults who are in the hospital, with the goal of finding ways to keep patients safer by identifying which drugs could be causing this serious condition.

More Delirium research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham
NIH-funded
Lab location1 site (Birmingham, United States)
Project startDecember 1, 2023
Project endNovember 30, 2025
Funding year2025
Award (this year)$177,865
NIH project number5R21AG084218-02
Project IDNIH-10989899 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are hospitalized individuals aged 65 and older who are receiving medications.

Less likely to help

Patients under the age of 65 or those not taking medications during hospitalization may not benefit from this research.

What this research studies

This research focuses on understanding the role of medications in causing delirium, a serious condition affecting many hospitalized older adults. By analyzing a large dataset from the University of Alabama at Birmingham, which includes over 81,000 patients, the study aims to identify specific medications that may increase the risk of delirium. Using advanced data mining techniques, researchers will explore patterns and associations in medication use and delirium occurrence. This approach seeks to improve patient safety by identifying preventable causes of delirium related to medication.

Why it matters

Potential benefit: If successful, this research could lead to better medication management and reduced incidence of delirium in older adults, enhancing their overall care and recovery.

How similar studies have gone: While there has been limited research specifically targeting medications as a cause of delirium, the innovative use of large datasets and data mining techniques in this study represents a novel approach.

Where this research is happening

  • University of Alabama at Birmingham
    Birmingham, United States
    Active

Researchers

  • Principal investigator: Kennedy, Richard E — University of Alabama at Birmingham
  • Study coordinator: Kennedy, Richard E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.